A new drug called Hercepting a monoclonal antibody by Genentech Inc., will reduce the probability of Cancer relapse to almost half. Moreover, the drug does not show any kinds of side effects.
This is definitely going to be a good news for all those women who lead their life under a threat that cancer might come back to them. The cost of the drug comes out to be $4,800 for a year and is covered by insurance.
